Cisapride marketed for use in gastroesophageal reflux disease.
D020117:Cisapride; D017277:Drug Approval; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D010880:Piperidines / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D010880:Piperidines; D012702:Serotonin Antagonists; D020117:Cisapride